Mansi Shah of Rutgers Cancer Institute, discusses multiple myeloma causes, treatment and research at NJ's ONLY NCI-designated Comprehensive Cancer Center. She found hope in a CAR T-cell therapy clinical trial at Rutgers Cancer Institute and Robert Wood Johnson University Hospital. Learn moreĪlready busy caring for a school-aged, special needs child, Tennica Johnson-Campbell faced another challenge in battling multiple myeloma. Multiple myeloma is relatively uncommon, and raising awareness for the disease is important because it can help increase early detection and improve long-term outcomes. Portions of the above were originally published by the National Cancer Institute. At Rutgers Cancer Institute of New Jersey, our multidisciplinary team collaborates with experts across various programs within our center and throughout RWJBarnabas Health – providing our patients with a treatment plan tailored just for them. Our program is led by international experts in the field. New types of treatment for multiple myeloma also are being explored in clinical trials. There are different types of treatment for patients with multiple myeloma including chemotherapy, targeted therapy, high-dose chemotherapy with stem cell transplant, immunotherapy, radiation therapy, surgery, and watchful waiting. Increased number and severity of infections due to the loss of antibody diversity.Bone and back pain secondary to weakening of the bones.Although some patients have minimal or no symptoms, other patients with more advanced disease can have symptoms related to the presence of the high number of plasma cells making only one antibody. Multiple myeloma is often not diagnosed unless specific tests, like the simple blood test serum protein electrophoresis (SPEP) are performed. Multiple myeloma cells also damage and weaken the bone. This can cause the blood to thicken and keep the bone marrow from making enough healthy blood cells. As the number of multiple myeloma cells increases, more antibodies are made. Normal plasma cells make antibodies to help the body fight infection and disease. Multiple myeloma cells are abnormal plasma cells (a type of white blood cell) that build up in the bone marrow and form tumors in many bones of the body. Palliative Medicine and Supportive Care Program.Sarcoma and Soft Tissue Oncology Program.Mesothelioma Treatment and Research Program.Liver Cancer and Bile Duct Cancer Program.Leukemia/Lymphoma/ Hematologic Malignancies.Genetic Counseling and Risk Assessment: The LIFE Center.Endocrine and Neuroendocrine Tumor Program.Breast Oncology: Stacy Goldstein Breast Cancer Center.Blood and Marrow Transplant and Cellular Therapies Program.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |